Insider Transactions in Q4 2024 at Eli Lilly & CO (LLY)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 16
2024
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
12
+0.39%
|
$9,348
$779.0 P/Share
|
|
Dec 16
2024
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
19
+0.12%
|
$14,801
$779.0 P/Share
|
|
Dec 16
2024
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
12
+0.47%
|
$9,348
$779.0 P/Share
|
|
Dec 16
2024
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
15
+0.03%
|
$11,685
$779.0 P/Share
|
|
Dec 16
2024
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
12
+0.63%
|
$9,348
$779.0 P/Share
|
|
Nov 18
2024
|
Karen Walker Director |
BUY
Grant, award, or other acquisition
|
Direct |
302
+4.61%
|
$219,554
$727.2 P/Share
|
|
Nov 18
2024
|
Jamere Jackson Director |
BUY
Grant, award, or other acquisition
|
Direct |
302
+3.19%
|
$219,554
$727.2 P/Share
|
|
Nov 18
2024
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
315
+4.79%
|
$229,005
$727.2 P/Share
|
|
Nov 18
2024
|
William G Kaelin Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
302
+1.39%
|
$219,554
$727.2 P/Share
|
|
Nov 18
2024
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
322
+0.98%
|
$234,094
$727.2 P/Share
|
|
Nov 18
2024
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
315
+5.65%
|
$229,005
$727.2 P/Share
|
|
Nov 18
2024
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
318
+0.29%
|
$231,186
$727.2 P/Share
|
|
Nov 18
2024
|
Katherine Baicker Director |
BUY
Grant, award, or other acquisition
|
Direct |
302
+1.29%
|
$219,554
$727.2 P/Share
|
|
Nov 18
2024
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
320
+0.44%
|
$232,640
$727.2 P/Share
|
|
Nov 18
2024
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
315
+7.38%
|
$229,005
$727.2 P/Share
|
|
Nov 08
2024
|
Donald A Zakrowski SVP, Finance, & CAO |
SELL
Open market or private sale
|
Direct |
900
-14.11%
|
$722,700
$803.38 P/Share
|
|
Nov 01
2024
|
Lucas Montarce EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
467
-4.05%
|
$382,006
$818.93 P/Share
|
|
Nov 01
2024
|
Lucas Montarce EVP & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,074
+8.51%
|
-
|
|
Nov 01
2024
|
Eric Dozier EVP, HR & Diversity |
SELL
Payment of exercise price or tax liability
|
Direct |
681
-7.81%
|
$557,058
$818.93 P/Share
|
|
Nov 01
2024
|
Eric Dozier EVP, HR & Diversity |
BUY
Exercise of conversion of derivative security
|
Direct |
1,534
+14.95%
|
-
|
|
Nov 01
2024
|
Edgardo Hernandez EVP & Pres., Mfg. Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
750
-2.39%
|
$613,500
$818.93 P/Share
|
|
Nov 01
2024
|
Edgardo Hernandez EVP & Pres., Mfg. Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
1,687
+5.1%
|
-
|
|
Oct 31
2024
|
Jacob Van Naarden EVP & Pres., Lilly Oncology |
SELL
Bona fide gift
|
Direct |
4,302
-26.64%
|
-
|
|
Oct 21
2024
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.41%
|
$9,966
$906.13 P/Share
|
|
Oct 21
2024
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
16
+0.1%
|
$14,496
$906.13 P/Share
|
|
Oct 21
2024
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.5%
|
$9,966
$906.13 P/Share
|
|
Oct 21
2024
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.02%
|
$11,778
$906.13 P/Share
|
|
Oct 21
2024
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.71%
|
$9,966
$906.13 P/Share
|